Another DNMTi drug called procainamide is known to partially inhibit the DNMT1 enzyme, and it protects against diabetes in mice with a deficiency in the unconventional prefoldin RPB5 interactor (URI), by decreasing PDX1 methylation levels and restoring PDX1 expression [152]. This evidence concerns the gene PDX1 and diabetes mellitus.